C4 Therapeutics Names Broad Institute’s Phillips CSO
Cambridge, MA-based C4 Therapeutics has named Andrew Phillips its chief scientific officer. Phillips was most recently an executive at the Broad Institute of MIT and Harvard, where he headed development of therapeutics. He was a chemistry professor at Yale University before that.
More from EXOME
Trending on Xconomy
Underwriters and Partners
Xpertise: Watch + Learn
Sponsored · Whitepaper
Accelerating Life Sciences Product Development & Commercialization
Best practices to drive digital adoption in life sciences
DocuSign
Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes
Sponsored · Whitepaper
Time Savings That Speed up Science
Monitor spending and save meaningful dollars with life sciences-specific rewards
Brex